Amgen To Acquire Privately Held Teneobio For $900 Million In Cash With Future Contingent Milestone Payments Biotech Investing
Johnson & Johnson to Participate in the Virtual Wells Fargo Healthcare Conference Medical Device Investing
AbbVie and Calico Announce Second Extension of Collaboration Focused on Aging and Age-Related Diseases Biotech Investing
BioHarvest Sciences Inc. Appoints Two Top Ranked Law Firms in the US and Canada to Pursue Regulatory Approvals of Its Upcoming Cannabis and Hemp Products Biotech Investing
Sixth Wave Expands AMIPs Applications and Provides Update on NSERC Grant Project Life Science Investing
Merck Announces Phase 3 KEYNOTE-355 Trial Met Primary Endpoint of Overall Survival in Patients with Metastatic Triple-Negative Breast Cancer Whose Tumors Expressed PD-L1 Pharmaceutical Investing
FDA Approves KEYTRUDA® for Treatment of Patients With High-Risk Early-Stage Triple-Negative Breast Cancer in Combination With Chemotherapy as Neoadjuvant Treatment, Then Continued as Single Agent as Adjuvant Treatment After Surgery Pharmaceutical Investing
Thermo Fisher Scientific Commits to Achieve Net-Zero Carbon Emissions by 2050 Medical Device Investing
